Upgrade to SI Premium - Free Trial

Bristol-Myers Squibb (BMY): IO Uncertainty Drives PT Decrease - BMO

July 28, 2017 7:01 AM
BMO Capital analyst, Alex Arfei, reiterated his Underperform rating on shares of Bristol-Myers Squibb Co. (NYSE: BMY) and cut the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles